ZA200209087B - Use of lactobacillus casei in immunostimulatory peptides. - Google Patents
Use of lactobacillus casei in immunostimulatory peptides.Info
- Publication number
- ZA200209087B ZA200209087B ZA200209087A ZA200209087A ZA200209087B ZA 200209087 B ZA200209087 B ZA 200209087B ZA 200209087 A ZA200209087 A ZA 200209087A ZA 200209087 A ZA200209087 A ZA 200209087A ZA 200209087 B ZA200209087 B ZA 200209087B
- Authority
- ZA
- South Africa
- Prior art keywords
- lactobacillus casei
- immunostimulatory peptides
- immunostimulatory
- peptides
- casei
- Prior art date
Links
- 244000199866 Lactobacillus casei Species 0.000 title 1
- 235000013958 Lactobacillus casei Nutrition 0.000 title 1
- 230000003308 immunostimulating effect Effects 0.000 title 1
- 229940017800 lactobacillus casei Drugs 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/245—Lactobacillus casei
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0006679A FR2809312B1 (fr) | 2000-05-25 | 2000-05-25 | Utilisation de l. casei dans des compositions immunostimulantes |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200209087B true ZA200209087B (en) | 2004-06-30 |
Family
ID=8850597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200209087A ZA200209087B (en) | 2000-05-25 | 2002-11-08 | Use of lactobacillus casei in immunostimulatory peptides. |
Country Status (28)
Country | Link |
---|---|
US (1) | US7604809B2 (de) |
EP (1) | EP1283714B1 (de) |
JP (1) | JP2003534284A (de) |
CN (1) | CN1194707C (de) |
AR (1) | AR028626A1 (de) |
AT (1) | ATE332143T1 (de) |
AU (2) | AU2001256435B2 (de) |
BG (1) | BG65884B1 (de) |
BR (1) | BR0111135A (de) |
CA (1) | CA2410350C (de) |
CZ (1) | CZ303600B6 (de) |
DE (1) | DE60121327T2 (de) |
DK (1) | DK1283714T3 (de) |
EA (1) | EA005081B1 (de) |
ES (1) | ES2267763T3 (de) |
FR (1) | FR2809312B1 (de) |
HK (1) | HK1055898A1 (de) |
HR (1) | HRP20020935A2 (de) |
HU (1) | HUP0302041A3 (de) |
IL (1) | IL152980A0 (de) |
MA (1) | MA25760A1 (de) |
MX (1) | MXPA02011636A (de) |
NO (1) | NO332369B1 (de) |
PL (1) | PL201801B1 (de) |
PT (1) | PT1283714E (de) |
SK (1) | SK18272002A3 (de) |
WO (1) | WO2001089541A1 (de) |
ZA (1) | ZA200209087B (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6800744B1 (en) * | 1997-07-02 | 2004-10-05 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
GB0009294D0 (en) | 2000-04-15 | 2000-05-31 | Sec Dep For The Home Departmen | Improvements in and relating to analysis of DNA samples |
US9610347B2 (en) * | 2001-04-30 | 2017-04-04 | Cortcontrol | Vaccination response for immunodeficiency or high cortisol |
CN1317385C (zh) * | 2003-05-30 | 2007-05-23 | 上海光明乳业股份有限公司 | 干酪乳杆菌Bd-II菌株及其在降低血脂方面的应用 |
US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
EP1629850B2 (de) * | 2004-08-24 | 2013-05-22 | N.V. Nutricia | Nahrungszusammensetzung die unverdauliche Transgalaktooligosaccharide sowie verdauliche Galaktose-Saccharide enthält |
ZA200705844B (en) * | 2004-12-15 | 2008-09-25 | Van Der Westhuzen Corne Floris | Detoxifying and immunity-booster composition |
EP1683425A1 (de) * | 2005-01-21 | 2006-07-26 | Compagnie Gervais Danone | Verwendung von fermentiertem Milchprodukt enthaltend L. Casei zur Herstellung eines Zusammensetzung zur Prävention oder Behandlung Überempfindlichkeitsreaktionen vom verzögerten Typ |
ES2264368B1 (es) * | 2005-02-11 | 2007-12-01 | Francisco Exposito Mesa | Complemento alimenticio o dietetico compuesto por productos procedentes del lisado de microorganismos. |
EP1885383B1 (de) | 2005-05-31 | 2016-09-21 | IAMS Europe B.V. | Katzen probiotisches bifidobacterium |
AR052472A1 (es) | 2005-05-31 | 2007-03-21 | Iams Company | Lactobacilos probioticos para felinos |
NZ575974A (en) | 2006-09-10 | 2012-03-30 | Glycotope Gmbh | Use of human cells of myeloid leukaemia origin for expression of antibodies |
FR2912657B1 (fr) * | 2007-02-16 | 2009-04-17 | Gervais Danone Sa | Utilisation de lactobacillus casei pour renforcer la protection induite par la vaccination anti-grippale. |
WO2009021585A1 (en) * | 2007-08-13 | 2009-02-19 | Dsm Ip Assets B.V. | Probiotic bacteria for rducing the occurence of symptoms of winter infections |
WO2009067000A1 (en) * | 2007-11-20 | 2009-05-28 | N.V. Nutricia | Composition with synbiotics |
EP2119365B1 (de) | 2008-05-13 | 2017-08-16 | Glycotope GmbH | Fermentationsprozess |
CA2722738C (en) * | 2008-05-13 | 2017-04-25 | Glycotope Gmbh | Fermentation process |
US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
EP2153837A1 (de) * | 2008-08-14 | 2010-02-17 | Compagnie Gervais Danone | Zusammensetzungen mit Lactobacillus casei zur Verbesserung der Resistenz gegen verbreitete Infektionskrankheiten |
FR2937252B1 (fr) | 2008-10-17 | 2011-05-20 | Pf Medicament | Association d'un extrait de sureau et d'une souche de l. paracasei. |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
EP2521769B1 (de) * | 2010-01-08 | 2016-05-18 | Compagnie Gervais Danone | Milchsäurebakterien mit antioxidierender wirkung |
BR112012023028B1 (pt) * | 2010-03-12 | 2020-12-08 | Compagnie Gervais Danone | meio fermentado por uma cepa de bactéria de ácido láctico, composição e seu uso |
EP2627198B1 (de) * | 2010-10-15 | 2015-09-02 | Chr. Hansen A/S | Immunadjuvans |
EP2455092A1 (de) * | 2010-11-11 | 2012-05-23 | Nestec S.A. | Nicht replizierende probiotische Mikroorganismen als Schutz vor Infektionen der oberen Atemwege |
ES2686313T3 (es) | 2011-08-22 | 2018-10-17 | Glycotope Gmbh | Microorganismos que portan un antígeno tumoral |
WO2014038929A1 (en) | 2012-09-07 | 2014-03-13 | N.V. Nutricia | Probiotics for producing antiviral factors |
SI3794042T1 (sl) | 2018-05-18 | 2024-07-31 | Daiichi Sankyo Co., Ltd. | Konjugat protitelesa anti-MUC1-exatecan in citotoksično sredstvo |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05236872A (ja) * | 1992-02-27 | 1993-09-17 | Takanashi Nyugyo Kk | 乳酸菌含有食品 |
JP4112021B2 (ja) * | 1994-02-16 | 2008-07-02 | 明治乳業株式会社 | 乳酸菌を用いた免疫賦活剤 |
ES2126962T3 (es) * | 1995-01-02 | 1999-04-01 | Gervais Danone Co | Fermento lactico, y su uso para la preparacion de productos antidiarreicos. |
JP3694236B2 (ja) * | 1997-08-21 | 2005-09-14 | ニュージーランド デアリー ボード | 免疫増強作用を有する乳酸菌 |
US6699517B2 (en) * | 1997-11-28 | 2004-03-02 | Compagnie Gervais Danone | Method for preparing food products by fermenting soy milk with streptococcus thermophilus |
IT1298918B1 (it) * | 1998-02-20 | 2000-02-07 | Mendes Srl | Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche |
KR100324441B1 (ko) * | 1999-02-08 | 2002-02-27 | 이은선 | 위염, 위궤양, 십이지장궤양 예방을 위한 식품 |
-
2000
- 2000-05-25 FR FR0006679A patent/FR2809312B1/fr not_active Expired - Fee Related
-
2001
- 2001-04-27 EP EP01929743A patent/EP1283714B1/de not_active Expired - Lifetime
- 2001-04-27 AU AU2001256435A patent/AU2001256435B2/en not_active Ceased
- 2001-04-27 WO PCT/FR2001/001310 patent/WO2001089541A1/fr active IP Right Grant
- 2001-04-27 CN CNB018100511A patent/CN1194707C/zh not_active Expired - Fee Related
- 2001-04-27 SK SK1827-2002A patent/SK18272002A3/sk not_active Application Discontinuation
- 2001-04-27 BR BR0111135-3A patent/BR0111135A/pt not_active IP Right Cessation
- 2001-04-27 CZ CZ20024189A patent/CZ303600B6/cs unknown
- 2001-04-27 DE DE60121327T patent/DE60121327T2/de not_active Expired - Lifetime
- 2001-04-27 HU HU0302041A patent/HUP0302041A3/hu unknown
- 2001-04-27 CA CA2410350A patent/CA2410350C/fr not_active Expired - Lifetime
- 2001-04-27 PL PL358408A patent/PL201801B1/pl unknown
- 2001-04-27 PT PT01929743T patent/PT1283714E/pt unknown
- 2001-04-27 AU AU5643501A patent/AU5643501A/xx active Pending
- 2001-04-27 EA EA200201248A patent/EA005081B1/ru not_active IP Right Cessation
- 2001-04-27 ES ES01929743T patent/ES2267763T3/es not_active Expired - Lifetime
- 2001-04-27 MX MXPA02011636A patent/MXPA02011636A/es active IP Right Grant
- 2001-04-27 AT AT01929743T patent/ATE332143T1/de active
- 2001-04-27 DK DK01929743T patent/DK1283714T3/da active
- 2001-04-27 US US10/276,315 patent/US7604809B2/en not_active Expired - Fee Related
- 2001-04-27 IL IL15298001A patent/IL152980A0/xx unknown
- 2001-04-27 JP JP2001585785A patent/JP2003534284A/ja active Pending
- 2001-05-24 AR ARP010102498A patent/AR028626A1/es unknown
-
2002
- 2002-11-08 ZA ZA200209087A patent/ZA200209087B/xx unknown
- 2002-11-20 BG BG107299A patent/BG65884B1/bg unknown
- 2002-11-21 NO NO20025595A patent/NO332369B1/no not_active IP Right Cessation
- 2002-11-25 HR HR20020935A patent/HRP20020935A2/hr not_active Application Discontinuation
- 2002-12-20 MA MA26968A patent/MA25760A1/fr unknown
-
2003
- 2003-11-12 HK HK03108188A patent/HK1055898A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200209087B (en) | Use of lactobacillus casei in immunostimulatory peptides. | |
AU2001256435A1 (en) | Use of lactobacillus casei in immunostimulatory compositions | |
IL160050A0 (en) | Probiotic lactobacillus casei strains | |
HUP0301003A3 (en) | Casein derived peptides and uses thereof in therapy | |
AU7616001A (en) | Probiotic recolonisation therapy | |
TWI317737B (en) | Membrane penetrating peptides and uses thereof | |
AU6079201A (en) | Lactobacillus reuteri glucosyltransferase | |
HUP0600031A2 (en) | Kahalalide formulations and their use | |
AU2001254856A1 (en) | Lactococcus lactis genome, polypeptides and uses | |
EP1343819A4 (de) | Hla-a2.1- bindungspeptide und ihre verwendung | |
GB0026134D0 (en) | Peptides and their use | |
SG97174A1 (en) | Lactobacillus rhamnosus strain and uses thereof | |
EP1275659A4 (de) | Physiologisch aktive peptide und anwendung derselben | |
HUP0300489A3 (en) | Novel protein and gene encoding the same | |
IL145527A0 (en) | Retro-inverso prosaposin-derived peptides and use thereof | |
EP1300416A4 (de) | Gedächtnisverstärkende peptide und deren verwendung(16.01.02) | |
GB0026136D0 (en) | Peptides and their use | |
GB0018148D0 (en) | Peptides and their use | |
GB0017028D0 (en) | Peptides and their therapeutic use | |
IL151351A0 (en) | Casein derived peptides and uses thereof in therapy | |
AU8557801A (en) | Modified proteins, isolated novel peptides, and uses thereof | |
AU5995701A (en) | Synthetic peptides and uses therefore | |
GB0002563D0 (en) | Virulence gene and protein and their use | |
GB0003725D0 (en) | Virulence gene and protein and their use | |
GB0002555D0 (en) | Virulence gene and protein and their use |